These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34525234)

  • 1. Treatment of palindromic rheumatism: A systematic review.
    Kavandi H; Hashemi SZ; Khalesi E; Khabbazi A
    Int J Clin Pract; 2021 Nov; 75(11):e14868. PubMed ID: 34525234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rituximab in resistant palindromic rheumatism: first report in literature.
    Raghavan P; Sreenath S; Cherian S; Shenoy PD
    Clin Rheumatol; 2019 Sep; 38(9):2399-2402. PubMed ID: 31076945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Palindromic Rheumatism a Pre-rheumatoid Arthritis Condition? Low Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy.
    Khabbazi A; Mirza-Aghazadeh-Attari M; Goli MT; Mahdavi AM; Hajialilo M; Rashtchizadeh N
    Reumatol Clin (Engl Ed); 2021 Jan; 17(1):7-11. PubMed ID: 30987884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of leflunomide in the treatment of palindromic rheumatism.
    Sadri M; Esalatmanesh K; Khabbazi A
    Int J Rheum Dis; 2022 Aug; 25(8):893-896. PubMed ID: 35666009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palindromic rheumatism: Evidence of four subtypes of palindromic-like arthritis based in either MEFV or rheumatoid factor/ACPA status.
    Cuervo A; Sanmartí R; Ramírez J; Castellanos-Moreira R; Inciarte-Mundo J; Aróstegui JI; McGonagle D; Cañete JD
    Joint Bone Spine; 2021 Dec; 88(6):105235. PubMed ID: 34098104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of patients with palindromic rheumatism treated with methotrexate.
    Ghassembaglou A; Esalatmanesh K; Gadakchi L; Nourmohammadi F; Khabbazi A
    Int J Rheum Dis; 2022 Apr; 25(4):489-495. PubMed ID: 35133068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?
    Castellanos-Moreira R; Rodriguez-Garcia SC; Gómez-Puerta JA; Ruiz-Esquide V; Camacho O; Ramírez J; Cuervo A; Morlà R; Cañete JD; Haro I; Sanmarti R
    J Rheumatol; 2020 May; 47(5):652-657. PubMed ID: 31371648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should we treat palindromic rheumatism? A systematic literature review.
    Corradini D; Di Matteo A; Emery P; Mankia K
    Semin Arthritis Rheum; 2021 Feb; 51(1):266-277. PubMed ID: 33401055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palindromic rheumatism: a unique and enigmatic entity with a complex relationship with rheumatoid arthritis.
    Sanmartí R; Haro I; Cañete JD
    Expert Rev Clin Immunol; 2021 Apr; 17(4):375-384. PubMed ID: 33666522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is palindromic rheumatism amongst children a benign disease?
    Butbul-Aviel Y; Uziel Y; Hezkelo N; Brik R; Amarilyo G
    Pediatr Rheumatol Online J; 2018 Feb; 16(1):12. PubMed ID: 29439723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.
    Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
    Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
    Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
    Haschka J; Englbrecht M; Hueber AJ; Manger B; Kleyer A; Reiser M; Finzel S; Tony HP; Kleinert S; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Wendler J; Schuch F; Ronneberger M; Lorenz HM; Nuesslein H; Alten R; Demary W; Henes J; Schett G; Rech J
    Ann Rheum Dis; 2016 Jan; 75(1):45-51. PubMed ID: 25660991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Nam JL; Ramiro S; Gaujoux-Viala C; Takase K; Leon-Garcia M; Emery P; Gossec L; Landewe R; Smolen JS; Buch MH
    Ann Rheum Dis; 2014 Mar; 73(3):516-28. PubMed ID: 24399231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What can palindromic rheumatism tell us?
    Mankia K; Emery P
    Best Pract Res Clin Rheumatol; 2017 Feb; 31(1):90-98. PubMed ID: 29221602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.